Liaoning Oxiranchem,Inc. (SHE:300082)
China · Delayed Price · Currency is CNY 12.36
+0.43 (3.60%)
Apr 29, 2026, 3:04 PM CST
Liaoning Oxiranchem,Inc. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 4,354 | 4,225 | 4,272 | 3,808 | 5,603 | 6,717 |
Other Revenue | - | - | 15.16 | 4.31 | 36.35 | - |
| 4,354 | 4,225 | 4,287 | 3,813 | 5,639 | 6,717 | |
Revenue Growth (YoY) | -2.65% | -1.43% | 12.44% | -32.39% | -16.05% | 17.67% |
Cost of Revenue | 4,142 | 4,021 | 4,177 | 3,868 | 5,400 | 6,071 |
Gross Profit | 212.41 | 204.7 | 110.25 | -55.15 | 239.43 | 646.79 |
Selling, General & Admin | 156.95 | 156.92 | 176.46 | 172.27 | 157.39 | 182.65 |
Research & Development | 44.39 | 44.99 | 43.74 | 54.13 | 55.75 | 50.04 |
Other Operating Expenses | -20.94 | -21.36 | 0.35 | 13.57 | 18.11 | 26.18 |
Operating Expenses | 180.4 | 180.55 | 227.72 | 246.07 | 228.69 | 270.19 |
Operating Income | 32.01 | 24.15 | -117.47 | -301.22 | 10.74 | 376.6 |
Interest Expense | - | - | -51.98 | -48.09 | -51.98 | -44.33 |
Interest & Investment Income | 43.52 | 21.89 | 3.58 | 10.92 | 52.08 | 72.48 |
Currency Exchange Gain (Loss) | - | - | -3.31 | 6.19 | -3.31 | 2.54 |
Other Non Operating Income (Expenses) | -52.46 | -20.69 | 9.31 | -2.57 | -5.5 | -6.6 |
EBT Excluding Unusual Items | 23.06 | 25.34 | -159.87 | -334.77 | 2.03 | 400.69 |
Impairment of Goodwill | - | - | - | -3.64 | -3.02 | - |
Gain (Loss) on Sale of Investments | -0.01 | 0 | -12.78 | -0.13 | 2.92 | 2.11 |
Gain (Loss) on Sale of Assets | 33.68 | 33.68 | -6.01 | 5.28 | 15.98 | -2.19 |
Asset Writedown | -21.24 | -24.52 | -1.05 | -34.95 | -11.71 | -2.2 |
Other Unusual Items | - | - | 13.38 | 18.2 | 16.43 | 21.24 |
Pretax Income | 35.49 | 34.51 | -166.33 | -350.01 | 22.63 | 419.65 |
Income Tax Expense | 1.73 | 7.3 | -18.05 | -49 | 3.71 | 47.54 |
Earnings From Continuing Operations | 33.76 | 27.2 | -148.28 | -301 | 18.92 | 372.12 |
Minority Interest in Earnings | -21.61 | -20.41 | -10.96 | -7.93 | -13.32 | -19.88 |
Net Income | 12.15 | 6.8 | -159.24 | -308.93 | 5.6 | 352.24 |
Net Income to Common | 12.15 | 6.8 | -159.24 | -308.93 | 5.6 | 352.24 |
Net Income Growth | - | - | - | - | -98.41% | -12.54% |
Shares Outstanding (Basic) | 681 | 680 | 692 | 687 | 560 | 677 |
Shares Outstanding (Diluted) | 681 | 680 | 692 | 687 | 560 | 677 |
Shares Change (YoY) | -1.79% | -1.82% | 0.85% | 22.69% | -17.39% | -0.76% |
EPS (Basic) | 0.02 | 0.01 | -0.23 | -0.45 | 0.01 | 0.52 |
EPS (Diluted) | 0.02 | 0.01 | -0.23 | -0.45 | 0.01 | 0.52 |
EPS Growth | - | - | - | - | -98.08% | -11.86% |
Free Cash Flow | -118.38 | -486.52 | -67.85 | 16.7 | 48.45 | 10.26 |
Free Cash Flow Per Share | -0.17 | -0.72 | -0.10 | 0.02 | 0.09 | 0.01 |
Dividend Per Share | - | - | - | - | - | 0.342 |
Dividend Growth | - | - | - | - | - | -4.20% |
Gross Margin | 4.88% | 4.84% | 2.57% | -1.45% | 4.25% | 9.63% |
Operating Margin | 0.73% | 0.57% | -2.74% | -7.90% | 0.19% | 5.61% |
Profit Margin | 0.28% | 0.16% | -3.72% | -8.10% | 0.10% | 5.24% |
Free Cash Flow Margin | -2.72% | -11.51% | -1.58% | 0.44% | 0.86% | 0.15% |
EBITDA | 207.47 | 205.8 | 88.98 | -37.23 | 262.98 | 613.93 |
EBITDA Margin | 4.76% | 4.87% | 2.08% | -0.98% | 4.66% | 9.14% |
D&A For EBITDA | 175.46 | 181.66 | 206.45 | 264 | 252.24 | 237.33 |
EBIT | 32.01 | 24.15 | -117.47 | -301.22 | 10.74 | 376.6 |
EBIT Margin | 0.73% | 0.57% | -2.74% | -7.90% | 0.19% | 5.61% |
Effective Tax Rate | 4.88% | 21.17% | - | - | 16.41% | 11.33% |
Revenue as Reported | - | - | 4,287 | 3,813 | 5,639 | 6,717 |
Advertising Expenses | - | - | - | - | - | 0.06 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.